The reading room / Peptide research blog

Peptide research, explained.

Detailed guides to peptide identity, biological pathways, analytical methods and clinical evidence. Search the reading room or follow a research topic.

Browse 13 research topics
Reset filters

All guides & articles

97–108 of 149 guides

Page 9 of 13
Lispro and glargine sequence-design cards beside a formulation vessel and chronometer in an insulin research file.Peptide Fundamentals

Insulin Analogues: How Sequence and Formulation Change the Profile

Insulin analogues show why small sequence changes and formulation choices can alter a peptide medicine’s time profile.

Updated 2026-10-29 ↗
intestinal epithelial teaching model with two clipped identity records Linaclotide and Plecanatide and one GC-C tab, in the Linaclotide vs Plecanatide research file.Peptide Fundamentals

Linaclotide vs Plecanatide: Peptides Acting in the Gut

Linaclotide and plecanatide are peptide GC-C agonists with product-specific gastrointestinal indications.

Updated 2026-10-29 ↗
Y-shaped antibody teaching model with two separately boxed peptide sample tags on an opened evidence tray, in the MariTide research file.Research Practice

MariTide: Why a Peptide–Antibody Conjugate Is a Different Design

MariTide, or maridebart cafraglutide, combines a peptide component with an antibody-based design. That architecture helps explain why it belongs in a discussion of metabolic peptides while differing from a standalone peptide analogue.

Updated 2026-10-29 ↗
Old somatostatin-reference envelope above two physically different formulation-study files Octreotide and Lanreotide, in the Octreotide vs Lanreotide research file.Peptide Fundamentals

Lanreotide vs Octreotide: Formulations and Trial Evidence

Compare lanreotide and octreotide by formulation, half-life and trial endpoint. PROMID and CLARINET tested each medicine against placebo, rather than against each other.

Updated 2026-11-05 ↗
Oral capsule conservation mount and a empty sealed formulation tube with two independent route-evidence envelopes, in the Oral vs Injectable Peptides research file.Peptide Fundamentals

Oral vs Injectable Peptides: Why Delivery Changes the Evidence

Oral and injectable describe routes, not two uniform classes of peptide evidence. A peptide may be intended to act locally in the gut or to reach a systemic target, and those aims require different delivery strategies.

Updated 2026-10-29 ↗
Small-molecule identity research container and an archived peptide reference strip, separate, under a GLP-1 target index tab, in the Orforglipron research file.Peptide Fundamentals

Orforglipron: Why a GLP-1 Drug Does Not Have to Be a Peptide

Orforglipron activates the GLP-1 receptor, but it is a small molecule rather than a peptide. That distinction is useful because online discussions often use GLP-1, injectable and peptide as if they were the same classification.

Updated 2026-10-29 ↗
Complement-system research assay tray with a single C3 specimen identity tab and independent clinical-context archive sleeves, in the Pegcetacoplan research file.Peptide Fundamentals

Pegcetacoplan: C3 Inhibition Across Different Clinical Contexts

Pegcetacoplan binds complement C3 and C3b, but that target description does not make its different clinical settings equivalent.

Updated 2026-10-29 ↗
Detailed liver teaching specimen with distinct histology-category archives Liver fat, Inflammation, Fibrosis, in the Pemvidutide and MASH research file.Research Practice

Pemvidutide and MASH: Liver Endpoints Beyond Weight Loss

Pemvidutide’s IMPACT report separates two liver-biopsy questions: MASH resolution without worsening fibrosis and fibrosis improvement without worsening MASH.

Updated 2026-10-29 ↗
Acetate and TFA counterion-analysis envelopes beside peptide identity and mass-balance records.Analytical Methods

Peptide Acetate vs TFA Salts: Identity, Content and Measurement

Acetate and trifluoroacetate describe counterion-related forms that need to be documented separately from a peptide’s sequence.

Updated 2026-10-29 ↗
Two physically distinct antique laboratory timepieces and sample-concentration and effect-duration archive strips, in the Peptide Half-Life vs Duration of Action research file.Peptide Fundamentals

Peptide Half-Life: Duration of Action, Decay and PRRT

Half-life is the time for a measured quantity to fall by half. In PRRT, it can describe physical decay, biological clearance or their effective combination.

Updated 2026-11-15 ↗
Y-shaped antibody teaching specimen partly exposed from an immunogenicity archive tray, with Binding and Neutralizing assay file tabs, in the Peptide Immunogenicity research file.Analytical Methods

Peptide Immunogenicity: What Anti-Drug Antibodies Can Tell You

Anti-drug antibodies are an assay-defined finding, not a complete diagnosis of harm or treatment failure.

Updated 2026-10-29 ↗
Three distinct research objects in separated evidence compartments: chromatography column, closed culture dish, endotoxin assay plate, in the Peptide Purity, Sterility and Endotoxin research file.Analytical Methods

Peptide Purity, Sterility and Endotoxin: Three Different Questions

Chemical purity, sterility and bacterial endotoxin testing ask different questions. A chromatographic percentage cannot answer all three, and a clear-looking solution cannot replace any of them.

Updated 2026-10-29 ↗
Peptide Research Guides & Evidence: Page 9 | PeptideTwo